Thyroid Disorders


Generic Levothyroxine as Effective as Brand Name for Achieving Thyrotropin Goals

October 01, 2020

Study suggests generic levothyroxine achieved similar rates of patients with thyrotropin levels in the ideal range as brand name levothyroxine.

Synthetic Medication, Desiccated Thyroid Similar in Effectiveness for Hypothyroidism

September 21, 2020

Results of the study offer clinicians greater insight and could improve decision-making in regards to treatment choices for hypothyroidism.

Study Finds Thyroid Inflammation Tied to Anxiety Disorders

September 19, 2020

A study from e-ECE 2020 suggests thyroid inflammation could put patients at greater risk for developing an anxiety disorder.

Nearly 1-in-3 of Physicians Could Be Overusing Thyroid Ultrasonography

August 14, 2020

A survey of more than 600 physicians found many endorsed the use of thyroid ultrasonography for clinically unsupported reasons.

Risk of Solid Cancer Death Not Influenced by Hyperthyroidism Treatment

July 24, 2020

New research is comparing the long-term risk of death from solid cancers in patients treated with radioactive iodine, antithyroid drugs, or surgery for hyperthyroidism.

Levothyroxine Fails to Provide Cardiac Benefit in Subclinical Hypothyroidism

July 21, 2020

New data disputes the findings of previous observational studies examining the effects of levothyroxine on cardiac function.

Study Reports First Known Case of Subacute Thyroiditis After COVID-19 Infection

May 21, 2020

A new case study published in The Journal of Clinical Endocrinology & Metabolism, reports on an 18-year-old patient with COVID-19 infection and subacute thyroiditis.

L-Thyroxine Ineffective In Patients With Subclinical Hypothyroidism, Study Says

May 04, 2020

The common synthetic thyroid medication L-thyroxine has been shown to be ineffective in reducing symptoms in patients with subclinical hypothyroidism (SCH), according to a study published in the Annals of Internal Medicine.

VIDEO: Teprotumumab Offers Hope for Thyroid Eye Disease Patients

April 14, 2020

New research shows teprotumumab can be a beneficial treatment for patients suffering from thyroid eye disease (TED), even across age, gender and risk factor-based subgroups. In an interview with HCPLive®, Raymond Douglas, MD, PhD, director of the Orbital and Thyroid Eye Disease Center at the Cedars-Sinai Medical Center, explained the importance of the teprotumumab in treating this patient group and how the coronavirus disease 2019 (COVID-19) might impact thyroid eye disease patients.

First Treatment for Thyroid Eye Disease Approved by FDA

January 22, 2020

The FDA announced yesterday that it has approved the first treatment for thyroid eye disease:  teprotumumab-trbw (Tepezza, Horizon Therapeutics).

Thyroid Treatment Can Aid in Adaption to Cold Environments

May 22, 2019

Restoring normal thyroid function may reverse cold-induced thermogenesis, say researchers writing in the journal Thyroid.

New Analysis Says No Need to Treat Subclinical Hypothyroidism

May 22, 2019

Adults with subclinical hypothyroidism do not need thyroid hormone therapy in most cases, states a BMJ Rapid Recommendation issued this month.

Treatment Recommendations for Cardiovascular Conditions with Thyroid Dysfunction

May 15, 2019

Thyroid hormones have a wide range of effects of the cardiovascular system. Too much or too little thyroiid hormones can induce or exacerbate existing cardiovascular disorders. In this article, we highlight the treatment recommendations for thyroid-related CVD events.

Endocrine Condition Associated with Chronic Opioid Use

May 01, 2019

Healthcare providers are increasingly looking for signs of opioid-induced adrenal insufficiency (OIAI) in their patients, according to a presentation made at the AACE annual meeting held in Los Angeles last week.

Should Pregnant Women be Screened for Thyroid Disease?

April 02, 2019

Primary care providers, endocrinologists and obstetricians have been challenged with the question of whether to screen all pregnant women for thyroid disease. The debate springs primarily from unknown clinical implications of subclinical thyroid disease during pregnancy. This issue was addressed at ENDO 2019.

Physician–patient interaction may influence prescribing patterns in hypothyroidism

February 13, 2019

Despite conflicting guidelines on how to treat hypothyroidism, U.S. physicians prescribe combination therapy more often than physicians around the world.

Interesting Endo: Reproductive and Adrenal Health

November 21, 2016

Our November list includes an injectable male contraceptive, resveratrol treatment for PCOS, and novel gene associated with Addison disease.

Surprising Finding: Alcohol and Thyroid Cancer

September 10, 2015

Is thyroid cancer the exception to the rule that alcohol consumption is linked to an increased risk of developing cancer?

Thyroid Cancer in the News

July 08, 2015

Recent findings in thyroid cancer treatment, including laser ablation therapy, lenvatinib, and guidelines for treating pediatric patients, are shown in the following slides.